Tsafrir Mor

Tsafrir Mor is a molecular biologist and biochemist affiliated with Arizona State University's School of Life Sciences, where he holds a researcher role at the Biodesign Institute's Center for Infectious Diseases and Vaccinology. His work focuses on leveraging plants for the production of therapeutic proteins, vaccines, and enzymes, particularly targeting HIV and neurotoxin countermeasures.

Education: PhD in Biochemistry from the Hebrew University of Jerusalem.

Research Interests: Molecular pharming, plant-based biopharmaceuticals, HIV vaccine development, enzyme engineering (e.g., butyrylcholinesterase), and mucosal vaccine technologies. His team explores plant-derived solutions for medical challenges such as nerve agent antidotes and antiviral therapies.

Grants & Collaborations: Active roles in NIH-funded projects on cocaine hydrolase gene therapy and plant-based bioscavengers. Collaborates with institutions like Mayo Clinic and the US Army Medical Research Institute.

Labs/Teams: Lead researcher in molecular pharming and infectious disease projects at the Biodesign Institute, with expertise in recombinant protein expression and vaccine antigen design.